Relevance of genotyping non-small-cell lung cancer patients on response to platinum-basedchemotherapy and tyrosine kinase inhibitors

被引：0
|
作者：
Campos-Parra, Alma D.
Cruz, Graciela
Zuloaga, Carlos
Aviles, Alejandro
Manriquez, Maria E. Vazquez
Borbolla-Escoboza, Jose R.
Cardona, Andres
Abelardo, Meneses
Arrieta, Oscar
机构：
来源：
CLINICAL CANCER RESEARCH | 2012年 / 18卷 / 03期
关键词：
D O I：
10.1158/1078-0432.12AACRIASLC-B3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B3
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors
    A F Gazdar
    Oncogene, 2009, 28 : S24 - S31
  • [22] Brain metastases in non-small-cell lung cancer: are tyrosine kinase inhibitors and checkpoint inhibitors now viable options?
    Morin-Ben Abdallah, S.
    Wong, A.
    CURRENT ONCOLOGY, 2018, 25 : S103 - S114
  • [23] Ceritinib: A New Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer
    Cooper, Maryann R.
    Chim, Helen
    Chan, Hoyi
    Durand, Cheryl
    ANNALS OF PHARMACOTHERAPY, 2015, 49 (01) : 107 - 112
  • [24] Predicting clinical benefit in non-small-cell lung cancer patients treated with epidermal growth factor tyrosine kinase inhibitors
    Amler, L. C.
    Goddard, A. D.
    Hillan, K. J.
    MOLECULAR APPROACHES TO CONTROLLING CANCER, 2005, 70 : 483 - 488
  • [25] INCIDENCE OF HEPATITIS B REACTIVATION DURING EGFR TYROSINE KINASE INHIBITORS TREATMENT IN NON-SMALL-CELL LUNG CANCER PATIENTS
    Yao, Zong-Han
    Liao, Wei-Yu
    Ho, Chao-Chi
    Chen, Kuan-Yu
    Shih, Jin-Yuan
    Chen, Jin-Shing
    Lin, Zhong-Zhe
    Lin, Chia-Chi
    Yang, James Chih-Hsin
    Yu, Chong-Jen
    RESPIROLOGY, 2018, 23 : 291 - 291
  • [26] Update of epidermal growth factor receptor-tyrosine kinase inhibitors in non-small-cell lung cancer
    Chen, Yuh-Min
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2013, 76 (05) : 249 - 257
  • [27] Tyrosine Kinase Inhibitors for Acute Respiratory Failure Because of Non-small-Cell Lung Cancer Involvement in the ICU
    Tandjaoui-Lambiotte, Yacine
    Akrour, Yanis
    Gibelin, Aude
    Gonzalez, Frederic
    Stoclin, Annabelle
    Moreau, Anne-Sophie
    Jaubert, Paul
    Oppenheimer, Anne
    Duchemann, Boris
    Gaudry, Stephane
    CHEST, 2022, 161 (01) : 284 - 287
  • [28] Predictive Biomarkers to Tyrosine Kinase Inhibitors for the Epidermal Growth Factor Receptor in Non-Small-Cell Lung Cancer
    De Luca, A.
    Normanno, N.
    CURRENT DRUG TARGETS, 2010, 11 (07) : 851 - 864
  • [29] EGF receptor tyrosine kinase inhibitors in the treatment of brain metastases from non-small-cell lung cancer
    Bartolotti, Marco
    Franceschi, Enrico
    Brandes, Alba Ariela
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (11) : 1429 - 1435
  • [30] The Use of EGFR Tyrosine Kinase Inhibitors in EGFR Wild-Type Non-Small-Cell Lung Cancer
    Stinchcombe, Thomas E.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2016, 17 (04)
12345